JP2013501047A5 - - Google Patents

Download PDF

Info

Publication number
JP2013501047A5
JP2013501047A5 JP2012523650A JP2012523650A JP2013501047A5 JP 2013501047 A5 JP2013501047 A5 JP 2013501047A5 JP 2012523650 A JP2012523650 A JP 2012523650A JP 2012523650 A JP2012523650 A JP 2012523650A JP 2013501047 A5 JP2013501047 A5 JP 2013501047A5
Authority
JP
Japan
Prior art keywords
atoms
hal
nhco
conh
nhconh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012523650A
Other languages
English (en)
Japanese (ja)
Other versions
JP5718332B2 (ja
JP2013501047A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/043467 external-priority patent/WO2011017142A1/en
Publication of JP2013501047A publication Critical patent/JP2013501047A/ja
Publication of JP2013501047A5 publication Critical patent/JP2013501047A5/ja
Application granted granted Critical
Publication of JP5718332B2 publication Critical patent/JP5718332B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012523650A 2009-08-06 2010-07-28 新規な二環式尿素化合物 Expired - Fee Related JP5718332B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23187309P 2009-08-06 2009-08-06
US61/231,873 2009-08-06
PCT/US2010/043467 WO2011017142A1 (en) 2009-08-06 2010-07-28 Novel bicyclic urea compounds

Publications (3)

Publication Number Publication Date
JP2013501047A JP2013501047A (ja) 2013-01-10
JP2013501047A5 true JP2013501047A5 (enExample) 2013-09-12
JP5718332B2 JP5718332B2 (ja) 2015-05-13

Family

ID=42985363

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012523650A Expired - Fee Related JP5718332B2 (ja) 2009-08-06 2010-07-28 新規な二環式尿素化合物

Country Status (14)

Country Link
US (1) US8569295B2 (enExample)
EP (1) EP2461869B1 (enExample)
JP (1) JP5718332B2 (enExample)
KR (1) KR20120055608A (enExample)
CN (1) CN102573994B (enExample)
AU (1) AU2010281368C1 (enExample)
CA (1) CA2770156C (enExample)
EA (1) EA201200218A1 (enExample)
ES (1) ES2433230T3 (enExample)
IL (1) IL217651A (enExample)
MX (1) MX2012001419A (enExample)
SG (1) SG178271A1 (enExample)
WO (1) WO2011017142A1 (enExample)
ZA (1) ZA201201635B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2740746A1 (en) 2008-10-14 2010-04-22 Ning Xi Compounds comprising a spiro-ring and and methods of use
EP2408300B1 (en) 2009-03-21 2016-05-11 Sunshine Lake Pharma Co., Ltd. Amino ester derivatives, salts thereof and methods of use
US9290485B2 (en) 2010-08-04 2016-03-22 Novartis Ag N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
RU2568258C2 (ru) 2011-02-28 2015-11-20 Саншайн Лейк Фарма Ко., Лтд Замещенные соединения хинолина и способы их использования
AU2012294917A1 (en) 2011-08-10 2014-03-20 Merck Patent Gmbh Pyrido-pyrimidine derivatives
GB201201566D0 (en) * 2012-01-30 2012-03-14 Vernalis R&D Ltd New chemical compounds
JP6342392B2 (ja) 2012-07-28 2018-06-13 カリター・サイエンシーズ・エルエルシー 置換型ピラゾロン化合物及び使用方法
US8975282B2 (en) 2012-07-28 2015-03-10 Sunshine Lake Pharma Co., Ltd. Substituted pyrazolone compounds and methods of use
JP2015530378A (ja) 2012-08-29 2015-10-15 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung 変形性関節症の処置のためのddr2インヒビター
US9663486B2 (en) 2013-10-14 2017-05-30 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
TWI624467B (zh) 2013-10-14 2018-05-21 衛材R&D企管股份有限公司 選擇性經取代之喹啉化合物
CN106279147A (zh) * 2015-05-21 2017-01-04 中国科学院上海药物研究所 一种吡啶并氮杂环化合物及其制备方法和用途
EP3440052B1 (en) * 2016-04-06 2023-10-25 University Of Oulu Compounds for use in the treatment of cancer
JP2021506735A (ja) * 2017-05-26 2021-02-22 イクノス サイエンシズ エスエー 新規map4k1阻害剤
GB2575490A (en) 2018-07-12 2020-01-15 Recordati Ind Chimica E Farmaceutica Spa P2X3 receptor antagonists
ES2985569T3 (es) * 2018-08-24 2024-11-06 Transthera Sciences Nanjing Inc Nuevo inhibidor de derivado de quinolina
KR20210126077A (ko) * 2019-02-11 2021-10-19 피닉스 몰레큘라 디자인스 Rsk 억제제의 결정형
CN112625026B (zh) * 2019-09-24 2022-09-09 药捷安康(南京)科技股份有限公司 Tam家族激酶抑制剂的喹啉衍生物
WO2021197276A1 (en) 2020-03-30 2021-10-07 Hutchison Medipharma Limited Amide compounds and uses thereof
CN112225748B (zh) * 2020-10-20 2021-11-30 四川大学华西医院 一种具有flt3激酶抑制活性的小分子化合物及其应用
WO2022175514A1 (en) 2021-02-22 2022-08-25 Bayer Aktiengesellschaft N-(pyridin-2-yl)-acetamides as p2x3 inhibitors
KR102726416B1 (ko) * 2021-12-15 2024-11-05 한국과학기술연구원 엑토뉴클레오티드 피로포스파타아제-포스포디에스터라아제의 저해 활성을 갖는 신규한 피리도피리미딘 유도체 및 이들의 용도
MX2024007444A (es) 2021-12-16 2024-09-02 Kinnate Biopharma Inc Inhibidores de cinasa met.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005533039A (ja) * 2002-05-29 2005-11-04 アムゲン インコーポレイテッド 細胞増殖関連疾患治療用2−オキソ−1,3,4−トリヒドロキナゾリニル誘導体
DE102004004731A1 (de) * 2004-01-30 2005-08-18 Merck Patent Gmbh Harnstoffderivate
EP1858889A1 (en) * 2005-03-08 2007-11-28 Biota Scientific Management Pty. Ltd. Bicyclic nucleosides and nucleotides as therapeutic agents
KR20080016659A (ko) * 2005-05-20 2008-02-21 버텍스 파마슈티칼스 인코포레이티드 단백질 키나제의 억제제로서 유용한 피롤로피리딘

Similar Documents

Publication Publication Date Title
JP2013521295A5 (enExample)
JP2016506962A5 (enExample)
JP2013518107A5 (enExample)
JP2010265321A5 (enExample)
JP2012092103A5 (enExample)
JP2014511891A5 (enExample)
JP2016503797A5 (enExample)
JP2012532899A5 (enExample)
JP2013542218A5 (enExample)
JP2013527242A5 (enExample)
JP2008510828A5 (enExample)
RU2014103587A (ru) Производные циклических аминов в качестве антагонистов рецептора ер4
AR086095A1 (es) Derivados de nucleosidos 2’-sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
JP2011503103A5 (enExample)
JP2018533593A5 (enExample)
JP2014511892A5 (enExample)
JP2012072150A5 (enExample)
JP2013534248A5 (enExample)
RU2015118647A (ru) Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr
JP2013508279A5 (enExample)
JP2017537949A5 (enExample)
JP2013544276A5 (enExample)
JP2014500295A5 (enExample)
JP2015512946A5 (enExample)
JP2015051983A5 (enExample)